Omnicell Operating Income 2010-2024 | OMCL
Omnicell operating income from 2010 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
| Omnicell Annual Operating Income (Millions of US $) |
|
|---|---|
| 2024 | $0 |
| 2023 | $-35 |
| 2022 | $-2 |
| 2021 | $90 |
| 2020 | $36 |
| 2019 | $78 |
| 2018 | $44 |
| 2017 | $11 |
| 2016 | $21 |
| 2015 | $49 |
| 2014 | $50 |
| 2013 | $35 |
| 2012 | $27 |
| 2011 | $16 |
| 2010 | $10 |
| 2009 | $1 |
| Omnicell Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2024-12-31 | $12 |
| 2024-09-30 | $7 |
| 2024-06-30 | $3 |
| 2024-03-31 | $-22 |
| 2023-12-31 | $-23 |
| 2023-09-30 | $4 |
| 2023-06-30 | $8 |
| 2023-03-31 | $-23 |
| 2022-12-31 | $-38 |
| 2022-09-30 | $18 |
| 2022-06-30 | $12 |
| 2022-03-31 | $5 |
| 2021-12-31 | $12 |
| 2021-09-30 | $29 |
| 2021-06-30 | $29 |
| 2021-03-31 | $20 |
| 2020-12-31 | $20 |
| 2020-09-30 | $10 |
| 2020-06-30 | $-7 |
| 2020-03-31 | $12 |
| 2019-12-31 | $22 |
| 2019-09-30 | $25 |
| 2019-06-30 | $19 |
| 2019-03-31 | $13 |
| 2018-12-31 | $19 |
| 2018-09-30 | $17 |
| 2018-06-30 | $7 |
| 2018-03-31 | $1 |
| 2017-12-31 | $16 |
| 2017-09-30 | $12 |
| 2017-06-30 | $-1 |
| 2017-03-31 | $-17 |
| 2016-12-31 | $15 |
| 2016-09-30 | $5 |
| 2016-06-30 | $-0 |
| 2016-03-31 | $2 |
| 2015-12-31 | $12 |
| 2015-09-30 | $14 |
| 2015-06-30 | $12 |
| 2015-03-31 | $10 |
| 2014-12-31 | $13 |
| 2014-09-30 | $14 |
| 2014-06-30 | $13 |
| 2014-03-31 | $10 |
| 2013-12-31 | $11 |
| 2013-09-30 | $11 |
| 2013-06-30 | $9 |
| 2013-03-31 | $4 |
| 2012-12-31 | $10 |
| 2012-09-30 | $11 |
| 2012-06-30 | $2 |
| 2012-03-31 | $4 |
| 2011-12-31 | $6 |
| 2011-09-30 | $5 |
| 2011-06-30 | $4 |
| 2011-03-31 | $1 |
| 2010-12-31 | $2 |
| 2010-09-30 | $3 |
| 2010-06-30 | $3 |
| 2010-03-31 | $2 |
| 2009-12-31 | $1 |
| 2009-09-30 | $1 |
| 2009-06-30 | $1 |
| 2009-03-31 | $-3 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.635B | $1.112B |
| Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution, a decision support application, and a Web-based procurement application. The products offered by the company enable care providers to improve patient safety and increase efficiency by lowering costs. The company also adheres to regulatory compliances and addresses issues related to population health. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $37.685B | 52.05 |
| Tempus AI (TEM) | United States | $8.308B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $6.565B | 105.54 |
| Inspire Medical Systems (INSP) | United States | $4.740B | 92.07 |
| IRhythm Technologies (IRTC) | United States | $3.288B | 0.00 |
| Privia Health (PRVA) | United States | $2.706B | 204.09 |
| Enovis (ENOV) | United States | $2.177B | 13.50 |
| Clover Health Investments (CLOV) | United States | $1.834B | 0.00 |
| Azenta (AZTA) | United States | $1.583B | 73.70 |
| Phreesia (PHR) | United States | $1.502B | 0.00 |
| Schrodinger (SDGR) | United States | $1.442B | 0.00 |
| 10x Genomics (TXG) | United States | $1.068B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.554B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.522B | 0.00 |
| Veradigm (MDRX) | United States | $0.469B | 0.00 |
| Talkspace (TALK) | United States | $0.431B | 256.00 |
| TruBridge (TBRG) | United States | $0.411B | 0.00 |
| Standard BioTools (LAB) | United States | $0.409B | 0.00 |
| Claritev (CTEV) | United States | $0.334B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.318B | 0.00 |
| Pulmonx (LUNG) | United States | $0.268B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.238B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.221B | 0.00 |
| American Well (AMWL) | United States | $0.123B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.090B | 0.00 |
| 111 (YI) | China | $0.069B | 0.00 |
| HeartBeam (BEAT) | United States | $0.068B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.067B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.059B | 0.00 |
| CareCloud (CCLD) | United States | $0.059B | 2.53 |
| Zepp Health (ZEPP) | China | $0.045B | 0.00 |
| Outset Medical (OM) | United States | $0.040B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.034B | 0.00 |
| Zhongchao (ZCMD) | China | $0.032B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| Movano (MOVE) | United States | $0.012B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.012B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.003B | 0.00 |
| Syra Health (SYRA) | United States | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |